Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from HAE

3 Medical Stocks to Buy for Future Investments

The medical industry is expected to grow due to robust demand and technological advancement. Therefore, investors could consider buying fundamentally strong medical stocks, Medtronic (MDT), Haemonetics (HAE) and HealthStream (HSTM), for the long term. Keep reading.

Are These 3 Medical Stocks a Safe Investment?

Are These 3 Medical Stocks a Safe Investment?

The future of the medical devices and equipment industry looks buoyant, given rising chronic conditions and the adoption of advanced technology. Given this backdrop, would it be prudent for investors to buy medical stocks, Terumo Corporation (TRUMY), Haemonetics Corp. (HAE), and MiMedx Group (MDXG)? Read more to find out….

3 Growth Stocks From the Medical Sector to Watch

3 Growth Stocks From the Medical Sector to Watch

Despite an uncertain macroeconomic environment, the medical sector should remain robust due to inelastic demand. Therefore, investors could consider adding medical stocks Medtronic (MDT), Smith & Nephew (SNN), and Haemonetics (HAE), which look poised to grow, to their watchlists. Keep reading.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

4 Medical Stocks That Could Help the Health of Investors’ Portfolios

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

Haemonetics, Top-Notch Medical Stock, Flirts With Breakout On Quarterly Beat

Haemonetics easily beat fiscal first-quarter estimates on Wednesday and raised its outlook for the year. HAE stock popped.

Investors Business Daily

Raymond James Thinks Haemonetics Growth Is 'Underappreciated'

Earlier this week, Raymond James attended Haemonetics Corp's (NYSE:HAE) Investor Day, where the management team presented a new Long-Range Plan (LRP), including some upside on the profitability, outlining each business unit's positioning and pipeline. According to the analysts, the plan implies an upside to expectations, despite some conservatism and back-end weight. Raymond James rolled…

Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds

Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26.

inkl

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings For Haemonetics

Analyst Ratings For Haemonetics

Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter:

Why Haemonetics Shares Are Trading Higher Today?

Why Haemonetics Shares Are Trading Higher Today?

Haemonetics Corporation (NYSE: HAE) posted

People

Steve Reitmeister

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Cardinal Health Inc

Novo Nordisk AS

AmerisourceBergen Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play